Status:
RECRUITING
Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia
Lead Sponsor:
University Hospital, Essen
Conditions:
Hereditary Hemorrhagic Telangiectasia
Eligibility:
All Genders
18+ years
Brief Summary
Patients with hereditary hemorrhagic telangiectasia (HHT) suffer from an inherited disorder leading to systemic vascular malformations. Mutations in several genes of the transforming growth factor (TG...
Detailed Description
Hereditary hemorrhagic telangiectasia (HHT) is characterized by systemic vascular malformations leading to recurrent bleedings and shunt formation especially in the liver, lungs and the brain. The und...
Eligibility Criteria
Inclusion
- diagnosed HHT (genetic testing and/ or fulfill at least 3 Curacao Criteria)
- older than 17 years
- ability to consent
Exclusion
- if inclusion Criteria are not met
Key Trial Info
Start Date :
August 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04469517
Start Date
August 10 2020
End Date
October 1 2026
Last Update
December 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Essen
Essen, North Rhine-Westphalia, Germany, 45147